Novo Nordisk’s $4.1 Billion Investment in North Carolina Set to Supercharge Production of Wegovy and Ozempic
Novo Nordisk to Build $4.1 Billion North Carolina Facility to Boost Output of Wegovy & Ozempic The global healthcare industry is witnessing a